PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 51 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $89,000 | -14.4% | 80,710 | +7.0% | 0.00% | – |
| Q2 2020 | $104,000 | +16.9% | 75,461 | -3.6% | 0.00% | – |
| Q1 2020 | $89,000 | -47.6% | 78,258 | +5.2% | 0.00% | – |
| Q4 2019 | $170,000 | +153.7% | 74,379 | -7.0% | 0.00% | – |
| Q3 2019 | $67,000 | -81.2% | 79,975 | -78.1% | 0.00% | – |
| Q2 2019 | $356,000 | -27.3% | 365,049 | -6.3% | 0.00% | – |
| Q1 2019 | $490,000 | -60.8% | 389,631 | +1.0% | 0.00% | – |
| Q4 2018 | $1,250,000 | +91.1% | 385,756 | +42.0% | 0.00% | – |
| Q3 2018 | $654,000 | -13.0% | 271,583 | +0.8% | 0.00% | – |
| Q2 2018 | $752,000 | +268.6% | 269,451 | +526.1% | 0.00% | – |
| Q1 2018 | $204,000 | +47.8% | 43,034 | +82.2% | 0.00% | – |
| Q4 2017 | $138,000 | +91.7% | 23,618 | -31.1% | 0.00% | – |
| Q3 2017 | $72,000 | -58.9% | 34,292 | -8.5% | 0.00% | – |
| Q2 2017 | $175,000 | -79.3% | 37,492 | -65.3% | 0.00% | – |
| Q1 2017 | $844,000 | -33.5% | 108,034 | +4.4% | 0.00% | – |
| Q4 2016 | $1,269,000 | -0.3% | 103,524 | +26.8% | 0.00% | – |
| Q3 2016 | $1,273,000 | +29.8% | 81,660 | +0.9% | 0.00% | – |
| Q2 2016 | $981,000 | +921.9% | 80,892 | +708.7% | 0.00% | – |
| Q1 2016 | $96,000 | – | 10,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,350,000 | $36,636,000 | 4.04% |
| EcoR1 Capital, LLC | 602,315 | $9,390,000 | 2.88% |
| NEA Management Company, LLC | 3,556,778 | $55,450,000 | 2.49% |
| Opaleye Management Inc. | 152,000 | $2,370,000 | 1.24% |
| Avoro Capital Advisors LLC | 179,565 | $2,799,000 | 0.49% |
| Monashee Investment Management LLC | 85,000 | $1,325,000 | 0.47% |
| Rock Springs Capital Management LP | 450,000 | $7,016,000 | 0.44% |
| Perceptive Advisors | 344,550 | $5,372,000 | 0.35% |
| Hillhouse Capital Management | 763,790 | $11,907,000 | 0.24% |
| Eventide Asset Management | 220,000 | $3,430,000 | 0.21% |